Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Performance characteristics for an immunoassay.

S K Vadlamudi1, W D Stewart, K J Fugate

  • 1Division of Clinical Laboratory Devices, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland 20850.

Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|January 1, 1991
PubMed
Summary

The US Medical Device Amendments of 1976 classify devices into three classes. Class III immunology devices require premarket approval, with performance validated through clinical trials and laboratory studies like sensitivity and specificity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cases from Practice.

The Indian medical gazette·2017
Same author

Notes on Post-Mortem Examinations Conducted in the Pooree District.

The Indian medical gazette·2017
Same author

Notes on Post-Mortem Examinations Conducted in the Pooree District.

The Indian medical gazette·2017
Same author

Notes on Post-Mortem Examinations Conducted in the Pooree District.

The Indian medical gazette·2017
Same author

Wound of Abdomen, with Protrusion of Bowel; Recovery with Artificial Anus.

The Indian medical gazette·2017
Same author

Report on the Outbreak of Cholera in the Julpigoree District in 1872-73.

The Indian medical gazette·2017

Area of Science:

  • Medical Device Regulation
  • Immunology
  • Clinical Diagnostics

Background:

  • The US Medical Device Amendments of 1976 created a regulatory framework for medical devices.
  • Devices are categorized into Class I (General Controls), Class II (Performance Standards), and Class III (Premarket Approval).

Purpose of the Study:

  • To outline the regulatory classification of medical devices, particularly Class III immunology devices.
  • To describe the validation process for performance characteristics of immunoassay kits.

Main Methods:

  • Review of the US Medical Device Amendments of 1976.
  • Description of clinical trial methodologies for establishing analyte levels.
  • Enumeration of laboratory studies for immunoassay kit validation.

Related Experiment Videos

Main Results:

  • Class III devices, including immunology devices, require premarket approval.
  • Clinical trials determine analyte levels in diverse populations.
  • Laboratory studies assess key performance characteristics such as reproducibility, recovery, linearity, stability, specificity, and sensitivity.

Conclusions:

  • Premarket approval for Class III immunology devices is supported by robust clinical and laboratory data.
  • Comprehensive performance validation ensures the safety and effectiveness of immunoassay kits.